Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [ALNY] Alnylam Pharmaceuticals Inc
Data updated 2025-Jul-09 (Wednesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Jul-09 Wednesday
| Open | $316.87 | High | $322.68 +1.83% |
|---|---|---|---|
| Close | $320.87 | Low | $313.74 -0.99% |
| Volume | 1.03 Million 0.92x | Volatility | 2.85% |
| Change |
+$3.37
+1.06%
|
Streak | ↑ 1 days +1.06% |
| 20d SMA | $316.33 +1.4% | 50d SMA | $295.51 +8.6% | 100d SMA | $272.12 +17.9% | 200d SMA | $267.72 +19.9% |
| RSI | 58 | MACD | -1.23 | ADX | 31.5 | Stochastic Oscillator | 56.2 71.4 |
| CCI | 31.0 | ATR | 9.71 | OBV | 110 Million | Chaikin A/D | 83.5 Million |
| Market Cap | 19.1 B | PEG Ratio | Trailing P/E | Forward P/E | |||
| Price/Sales (ttm) | 10.3 | Price/Book (mrq) | EV/Revenue (ttm) | 9.82 | EV/EBITDA (ttm) | -83.4 | |
| % Held by Insiders | 0.40% | % Held by Institutions | 95.08% | Shares Short | 2.69 M | Shares Short (prior month) | 3.99 M |
| Short Ratio | 2.1 | Short % of Outstanding | 2.14% | Short % of Float | 2.14% | Shares Short Change (mom) | -32.6% |
| Revenue/Share (ttm) | $14.64 | Profit Margin (ttm) | -24.08% | Operating Margin (ttm) | -26.47% | EBITDA (ttm) | -228 M |
| Diluted EPS (ttm) | $-3.52 | Current Ratio (mrq) | 3.08 | Return on Assets (ttm) | -4.78% | Return on Equity (ttm) | |
| Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 31.20% | Operating Cash Flow (ttm) | 104 M | Free Cash Flow (ttm) | 147 M | |
Choose view type
Monthly Performance for Alnylam Pharmaceuticals Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Alnylam Pharmaceuticals Inc up to close of 2025-Jul-09 at $320.87
1-month Performance Benchmarks for Alnylam Pharmaceuticals Inc:
Related to Alnylam Pharmaceuticals Inc
Information for Alnylam Pharmaceuticals Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-09 on Google
SEC Reports : Quarterly reports around 2025-Jul-09 on SEC Edgar
Compare Alnylam Pharmaceuticals Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Alnylam Pharmaceuticals Inc
Industry : Biotechnology industry performance which includes Alnylam Pharmaceuticals Inc